Filing Details
- Accession Number:
- 0000950170-24-137425
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-17 17:36:21
- Reporting Period:
- 2024-12-15
- Accepted Time:
- 2024-12-17 17:36:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1850906 | Singular Genomics Systems Inc. | OMIC | Laboratory Analytical Instruments (3826) | 812948451 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1859701 | Andrew Spaventa | 3010 Science Park Road San Diego CA 92121 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-15 | 486 | $0.00 | 811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-16 | 180 | $20.16 | 631 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-16 | 306 | $0.00 | 325 | No | 4 | G | Direct | |
| Common Stock | Acquisiton | 2024-12-16 | 306 | $0.00 | 141,793 | No | 4 | G | Indirect | By The Andrew K. Spaventa Living Trust dated April 9, 2014 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | G | Indirect | By The Andrew K. Spaventa Living Trust dated April 9, 2014 |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-12-15 | 486 | $0.00 | 486 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,374 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 85 | Indirect | By Axon Holdings, LLC |
Footnotes
- Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted RSUs.
- Weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $20.34 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Immediately upon settlement of the vested RSUs, and following the withholding described above, the Reporting Person transferred the shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
- The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.
Billionaire Hedge Funds
